Guardant Health Stock Today

GH Stock  USD 25.29  1.77  7.53%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Over 53

 
High
 
Low
Average
Guardant Health is trading at 25.29 as of the 7th of November 2024. This is a 7.53 percent increase since the beginning of the trading day. The stock's open price was 23.52. Guardant Health has 53 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. Equity ratings for Guardant Health are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 11th of May 2024 and ending today, the 7th of November 2024. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
4th of October 2018
Category
Healthcare
Classification
Health Care
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company was incorporated in 2011 and is headquartered in Redwood City, California. Guardant Health operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. The company has 123.02 M outstanding shares of which 13.68 M shares are currently sold short in the market by investors with about 7.18 days to cover all shorted shares. More on Guardant Health

Moving against Guardant Stock

  0.86ICUI ICU MedicalPairCorr
  0.83GILD Gilead SciencesPairCorr
  0.8GNFT GenfitPairCorr
  0.78BMY Bristol Myers Squibb Aggressive PushPairCorr
  0.77VRDN Viridian TherapeuticsPairCorr
  0.77INBX Inhibrx Symbol ChangePairCorr

Guardant Stock Highlights

ESG Sustainability
Environmental
Governance
Social
CoCEO CoFounderHelmy Eltoukhy
Thematic IdeaHealthcare (View all Themes)
Business ConcentrationHealth Care Providers & Services, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Biotechnology, NASDAQ Health Care, Healthcare, Health Care, Health Care Providers & Services, Diagnostics & Research, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.160.3157
Way Down
Very volatile
Gross Profit Margin0.430.5974
Way Down
Slightly volatile
Total Current Liabilities112 M205.9 M
Way Down
Slightly volatile
Non Current Liabilities Total1.5 B1.4 B
Sufficiently Up
Slightly volatile
Total Assets1.4 B1.8 B
Way Down
Slightly volatile
Total Current Assets956.1 M1.3 B
Way Down
Slightly volatile
Debt Levels
Guardant Health can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Guardant Health's financial leverage. It provides some insight into what part of Guardant Health's total assets is financed by creditors.
Liquidity
Guardant Health reports 1.35 B of total liabilities with total debt to equity ratio (D/E) of 4.32, which implies that the company may not be able to produce enough cash to satisfy its debt commitments. Guardant Health has a current ratio of 6.06, indicating that it is in good position to pay out its debt commitments in time. Note however, debt could still be an excellent tool for Guardant to invest in growth at high rates of return.

Change In Cash

1.04 Billion
Guardant Health (GH) is traded on NASDAQ Exchange in USA. It is located in 3100 Hanover Street, Palo Alto, CA, United States, 94304 and employs 1,768 people. Guardant Health is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a market capitalization of 3.11 B. Guardant Health is active under Health Care Providers & Services sector as part of Health Care industry. The entity has 123.02 M outstanding shares of which 13.68 M shares are currently sold short in the market by investors with about 7.18 days to cover all shorted shares. Guardant Health reports about 853.69 M in cash with (324.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.35.
Check Guardant Health Probability Of Bankruptcy
Ownership Allocation
The majority of Guardant Health outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Guardant Health to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Guardant Health. Please pay attention to any change in the institutional holdings of Guardant Health as this could imply that something significant has changed or is about to change at the company.
Check Guardant Ownership Details

Guardant Stock Institutional Holders

InstituionRecorded OnShares
Cadian Capital Management Lp2024-06-30
3.1 M
Fmr Inc2024-06-30
3.1 M
Braidwell Lp2024-06-30
2.8 M
Parkwood Llc2024-06-30
2.8 M
Geode Capital Management, Llc2024-06-30
2.8 M
State Street Corp2024-06-30
2.8 M
Millennium Management Llc2024-06-30
2.1 M
Fidelity International Ltd2024-06-30
2.1 M
Fuller & Thaler Asset Management Inc2024-06-30
1.9 M
Vanguard Group Inc2024-06-30
11.6 M
Blackrock Inc2024-06-30
11.2 M
View Guardant Health Diagnostics

Guardant Health Historical Income Statement

As of now, Guardant Health's Depreciation And Amortization is increasing as compared to previous years. The Guardant Health's current Interest Expense is estimated to increase to about 2.8 M, while Selling General Administrative is projected to decrease to under 118.7 M. View More Fundamentals

Guardant Stock Against Markets

Guardant Health Corporate Management

Jennifer HigginsSenior AffairsProfile
Stephen MurphySenior MarketingProfile
John SaiaChief SecretaryProfile
Christopher FreemanChief OfficerProfile
Zarak KhurshidVice RelationsProfile
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.11)
Revenue Per Share
5.358
Quarterly Revenue Growth
0.292
Return On Assets
(0.15)
Return On Equity
(3.37)
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.